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Abstract
Purpose: To compare three types of MRI liver iron
content (LIC) measurement performed in daily clinical
routine in a single center over a 6-year period.
Methods: Patients undergoing LIC MRI-scans (1.5T) at
our center between January 1, 2008 and December 31,
2013 were retrospectively included. LIC was measured
routinely with signal intensity ratio (SIR) and MR-
relaxometry (R2 and R2*) methods. Three observers
placed regions-of-interest. The success rate was the
number of correctly acquired scans over the total number
of scans. Interobserver agreement was assessed with
intraclass correlation coefficients (ICC) and Bland–
Altman analysis, correlations between LICSIR, R2, R2*,
and serum values with Spearman’s rank correlation
coefficient. Diagnostic accuracies of LICSIR, R2 and
serum transferrin, transferrin-saturation, and ferritin
compared to increased R2* (‡44 Hz) as indicator of iron
overload were assessed using ROC-analysis.
Results: LIC MRI-scans were performed in 114 subjects.
SIR, R2, and R2* data were successfully acquired in 102/
114 (89%), 71/114 (62%), and 112/114 (98%) measure-
ments, with the lowest success rate for R2. The ICCs of
SIR, R2, and R2* did not differ at 0.998, 0.997, and
0.999. R2 and serum ferritin had the highest diagnostic
accuracies to detect elevated R2* as mark of iron
overload.
Conclusions: SIR and R2* are preferable over R2 in terms
of success rates. R2*’s shorter acquisition time and wide
range of measurable LIC values favor R2* over SIR for
MRI-based LIC measurement.




LIC Liver iron content
Various diseases are associated with increased liver iron
content (LIC), which may induce or contribute to liver
damage [1–3]. Serial measurement of LIC during long-
term follow-up and treatment is highly desirable, but
repeated invasive measurements are not recommended
due to risks of complications of serial liver biopsies.
Surrogate biochemical markers including serum ferritin
and transferrin-saturation are widely used, but are
flawed by limited specificity. Thus, accurate non-invasive
MRI-based methods of LIC measurement are used in
clinical practice for patients (suspected) with increased
LIC [4, 5].
Several types of MRI LIC measurement have been
described in the literature. Straightforward in–out phase
gradient echo (GRE) shows signal loss at the later echo
time (TE) but is only qualitative and easily confounded
by the presence of hepatic steatosis. Quantitative ap-
proaches include (i) signal intensity ratio (SIR) mea-
surement (e.g., the Gandon method) and (ii) MR-
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relaxometry. The Gandon method (henceforth referred
to as ‘‘SIR’’) utilizes the liver-to-muscle SIR on differ-
ently weighted MRI-scans [6]. This method allows easy
and free calculation of the LICSIR, by entering ROI
values in an online tool [7]. Hence, assuming the acqui-
sition and placement of regions-of-interest (ROIs) are
performed correctly, the method is robust to observer
influences. A major limitation is its upper limit of
detection of 350 lmol/g (equal to 20 mg/g): changes
above that threshold cannot be measured.
MR-relaxometry relies on the calculation of tissue
relaxation rates (R2 and R2*, the inverse of relaxation
times T2 and T2*), which increase as iron accumulates
and are sensitive to changes in LIC values well above the
SIR-threshold. One commercialized R2 approach using
single-echo spin-echo (SE) MRI is the FDA-approved St.
Pierre method [FerriScan], performed in 10 min in free-
breathing [8]. The per-scan analysis price is ~$300, on top
of the costs of the MRI-scan itself. Alternative free-of-
charge approaches are available for R2 using free-
breathing or respiratory triggered SE-MRI and for R2*
using single breath-hold GRE MRI [9].
Recent developments in MR-relaxometry include
multipeak fat corrections and the use of complex instead of
magnitude-only data ﬁtting [10], assessment of the effect of
fat suppression on R2* [11] and the comparison of ad-
vanced data fit models [12] and analysis approaches [13].
A comparative study of LICSIR, R2, and R2* in 94
patients with b-thalassemia reported high correlations
[14]. However, success rates, interobserver agreement,
and applicability for diseases other than b-thalassemia
were not investigated, nor were serum markers assessed.
The latter may be useful to screen for elevated LIC (i.e.,
>36 lmol/g), saving expensive and limited MRI time.
We hypothesize that R2* is preferable over SIR and R2 in
terms of success rate, acquisition time, and range of
detection and over serum values in terms of accuracy in
detecting elevated LIC.
In our center, the clinical LIC protocol has included
SIR, R2, and R2* since 2005, with regular weekly clinical
referrals since 2008. The SIR measurement is recom-
mended by the national guideline for hemochromatosis
[15]. It is supplemented by R2 and R2* measurements to
fill the gap caused by the SIR method’s hard cut-off at
350 lmol/g. To investigate our hypothesis, we (i) as-
sessed SIR, R2, and R2* LIC measurements and their
success rates and interobserver agreement; and (ii) com-
pared the diagnostic accuracies of LICSIR, R2, and sur-
rogate serum markers for correctly predicting elevated
LIC based on increased R2*.
Materials and methods
Ethical
All data used for this study were acquired in clinical
setting and were anonymized prior to analysis. Informed
consent was waived by the Medical Research Ethics
Committee of the AMC Amsterdam.
Patients
All MRI-based LIC measurements performed between
January 1, 2008 and December 31, 2013 were retro-
spectively included in this study. As additional mea-
surements were added to the protocol in 2014, only
measurements up to end 2013 were included. Clinical
diagnosis and—when available—serum markers of iron
metabolism (total iron, transferrin, transferrin-satura-
tion, ferritin) were collected and subsequently anon-
ymized by a colleague not otherwise involved in this
study.
MRI
MRI-scanning was performed supine, feet ﬁrst on a 1.5T
Avanto MRI-scanner (Siemens AG, Erlangen, Germany)
using phased-array coils (body array and spine coil) for
localizers and R2 and R2* measurements and the body
coil for the SIR measurement [6]. Use of the body coil
provided an as homogenous B1 field as possible, reducing
variation in SIR measurements due to variations of flip
angles between patients. For R2* and R2, the B1 variation
is eliminated via the data fit. Breath-hold imaging (lo-
calizers, SIR and R2*) was performed in expiration.
Three 10-mm slices with a variable slice gap to cover the
liver were equally positioned for all three LIC measure-
ments. Especially for the GRE-based SIR and R2*
measurements, careful B0 shimming is important to
achieve a homogenous B0 field, ensuring correct mea-
surements. Shimming was performed with a shim box
covering the field-of-view in the feet-head direction and
the contours of the abdomen (i.e., excluding the arms) in
the left–right and anterior-posterior directions. The SIR
measurement according to Gandon et al. requires five
(T1, PD, T2, T2+, and T2++) image weightings with
specific TR/TE combinations [6]. Table 1 contains an
overview of the relevant scan parameters. Of note, the
TE interval used for R2* was shorter (1.41 ms) than the
standard in- and out-of-phase interval (2.26 ms).
Data analyses
After inclusion all measurements were checked for cor-
rect TRs, TEs, and RF coils using DICOM header
information as for SIR measurements, speciﬁc TR/TE
combinations and the use of the body coil are manda-
tory. Image quality was assessed by a research trainee
(JHR, 4 years of experience) and an abdominal radiol-
ogist (JS, 20 years of experience) using a 3-point scale
(good/adequate/inadequate). The type of artifact(s) was
noted. Measurements with incorrect scan parameters or
inadequate image quality were classiﬁed unsuccessful.
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ROI-placement
SIR, R2, and R2* data were processed using custom-
made software that allowed ROI-placement, LICSIR
calculation, and R2 and R2* data fitting. Three blinded
observers (JHR, MAT, and EMA) with four, a half and
9 years of experience, respectively, independently placed
regions-of-interest (ROIs) for three slices per scan. First,
the liver parenchyma was masked on R2* source data,
excluding a rim near the liver edge (Fig. 1A). Next, non-
liver voxels (e.g., vessels, gall bladder) inside the liver
contour were masked (Fig. 1B). By subtracting ROI-2
from ROI-1, only liver parenchyma remained (Fig. 1C).
Liver ROIs were copied from the R2* data for SIR
analysis, with two additional ROIs in both paraspinal
muscles, carefully avoiding areas of signal intensity loss
close to the lung (Fig. 1D). This also allowed a check to
identify whether patients had moved between R2* and
SIR measurements, in which case new ROIs were placed.
Ghosting artifacts caused by aortic blood flow were
present in SIR measurements before November 2012
(when saturation slabs were added). Separate ROIs were
placed to remove these artifacts from the liver and
muscle ROIs (Fig. 1E, F). Some reports indicate that
susceptibility artifacts may affect R2* measurements
when using a single ROI in liver segments VII or VIII
[16]. Due to the limited number of slices, we did not
formally assess segmental variations of R2, R2*, or
LICSIR in this study.
The respiratory triggering applied for R2 data acqui-
sition resulted in slight changes in slice positioning so
that new ROIs were placed using R2 source data as de-
scribed above.
LICSIR
The calculations published by Gandon et al. were entered
into the aforementioned program [7, 17], which auto-
matically chooses the most reliable SIR (i.e., T1, PD, T2,
T2+, or T2++) which is converted to LICSIR. The
mean LICSIR of three slices was used and, when one or
more values exceeded the 350 lmol/g threshold, the final
value was noted as >350 lmol/g. In two subanalyses,
the R2 and R2* values and the individual SIR ratios in
patients with LICSIR >350 lmol/g were evaluated.
Fig. 1. Placement of ROIs. A–F The placement of ROIs on
the data. A–C How the ROIs for the total liver parenchyma
(A) and intrahepatic vasculature and/or gall bladder (B)
are drawn and the result of subtraction in (C). D The
ROI-placement on the paraspinal muscles for SIR calcula-
tions. E, F The placement of a ghosting artifact ROI (E) and
the final liver parenchyma ROI (F) obtained by subtracting
(E) from (C).
Table 1. MRI parameters
SIR R2 R2*
Technique GRE SE GRE
TR (ms) 120 3000–4000a 300
TE1 (ms) Variable [7] 6.2 0.99
DTE (ms) n/a 6.2 1.41
Number of echoes 1 16 (multiecho) 12 (multiecho)
FA () Variable [7] 180 20
FOV (mm 9 mm) 380 9 285 380 9 285 380 9 285
Acquisition matrix 256 9 256 256 9 256 128 9 96b
Reconstruction matrix 256 9 192 256 9 192 256 9 192
Parallel imaging No GRAPPA GRAPPA
Acceleration factor n/a 2 2
Bandwidth (Hz/pixel) 140 465 1963
Slice thickness 10 10 10
Slice gap Variablec Variablec Variablec
Number of slices 3 3 3
Acquisition time 100 s (5 9 20 s) 9–16 mina 20 s
a Depending on the patient’s respiratory frequency: one TR per res-
piratory cycle
b Zero-padding was used to fit R2* acquisition in breath-hold time
(20 s)
c The slice gap was adjusted per patient so as to cover the whole liver
with the three slices
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R2*
In magnitude images, the noise is distributed in a non-
Gaussian manner. This is known as Rician noise [18]. At
high signal levels, the non-zero mean has a negligible
effect on the average signal, but near the noise level, a
noise bias exists which needs to be taken into account
when fitting R2*. We explored three different fit routines:
a truncated exponential fit (A) [19, 20], an exponen-
tial + constant fit (B) [9, 21], and an exponen-
tial + Rician noise (C).
The truncated exponential method A is considered
the reference standard, but is time-consuming, where
methods B + C do not require further manual input. We
compared method B and C with method A as reference
using Bland–Altman analysis and R2* data from a single
reader (EMA). Based on this comparison (mean paired
difference (d) was 0.8 Hz for A–C and 33.6 Hz for A–B),
we employed method C (Rician noise bias) for the
remaining analyses [22, 23].
R2* calculation was thus performed with a monoex-
ponential model (Eq. 1) with a Rician noise factor. In
Eq. 1, ER describes the Rice distribution (Online Re-
source 1), where r is a noise parameter and S0  eR2TE
reflects the true magnitude value. Data were averaged
inside the ROI before data fitting (average-then-fit).
S TEð Þ ¼ ER  S0  eR2TE; r
  ð1Þ
The effect of intrahepatic fat on R2* was assessed by
applying a biexponential model in a subset (n = 10) with
definite presence of fat, as identified by the presence of a
oscillating signal intensity decay over time.R2* valueswith
and without correction were compared using Bland–Alt-
man analysis. The (d) was 0.1 Hz—indicating low overall
fat content in this cohort—and deemed negligible com-
pared to the subset mean of 70 Hz. Monoexponentially
fitted R2* values were used for all comparisons.
R2
ForR2 calculation an average-then-fit routine was applied
using a biexponential model as shown in Eqs. 2 and 3. In
Eq. 2, ST (TE) is the signal intensity without noise at time
TE, S0 is the signal intensity at TE = 0, and R2 is the
relaxation rate. The subscripts a and b indicate fast and
slow relaxation components, respectively. For R2, Rician
noise bias was approximated by the Pythagorean addition
of an extra fit parameter, the noise factor ‘m’ in Eq. 3.
ST TEð Þ ¼ S0;a  eR2;aTE þ S0;b  eR2;bTE ð2Þ
S TEð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ST TEð Þ þ m2
q
: ð3Þ
In the biexponential model, an iron-dense and an
iron-sparse component are assumed, with short and long
R2, respectively. For further comparisons with LICSIR
and R2*, the bulk R2 was calculated (Eq. 4) in accor-
dance with the literature [8, 9, 14].
R2 ¼ S0;a  R2;a þ S0;b  R2;b
S0;a þ S0;b ð4Þ
Comparison with the literature
The relations between the LICSIR, R2, and R2* were
compared to published regression analysis results based
on either biopsy-proven LIC (LICBIOPSY) [8, 9, 19–21] or
LICSIR [14].
Statistical analyses
Data are described as number (%) or median (in-
terquartile range, IQR). Results of observers were com-
pared using a Friedman test and Wilcoxon Signed-Rank
test as post hoc. Success rates are deﬁned as the number
of correctly acquired scans of at least ‘‘adequate’’ quality
divided by the total number of measurements. These
were compared using a McNemar test. Correlations were
assessed with Spearman’s correlation coefﬁcients (rS),
interobserver agreement with two-way random, and
absolute intraclass correlation coefficients (ICCs). Both
were graded according to Landis et al. [24]. Bland–Alt-
man analysis was performed to compare accuracy be-
tween the three MRI methods for a single observer and
compare the performance of the three observers [22]. In a
separate analysis, the calculated R2 and R2* values were
converted to LICR2ðÞ values in lmol/g using the for-
mulas provided by St. Pierre et al. and Garbowski et al.
[8, 20] as these were established with image analysis
protocols similar to ours.
ROC-analyses were performed for LICSIR, R2, and
serum values with significant correlation with R2* to
establish their diagnostic accuracy to identify increased
R2*, i.e., ‡44 Hz [9]. R2* was chosen as a reference value
as it had the best success rate and shortest acquisition
time. The optimal cut-off value for R2 was found by
optimizing the Youden index, while for LICSIR we used
the established cut-off value of >36 lmol/g. P values of
<0.05 were accepted as statistically significant. Statisti-
cal analyses were performed using SPSS Version 22 (IBM
Corp, Armonk, NY), MedCalc Statistical Software ver-
sion 16.2.0 (MedCalc Software bvba, Ostend, Belgium;
https://www.medcalc.org; 2016), and GraphPad Prism
5.0 (GraphPad Software, La Jolla, CA).
Results
Patients
Between January 1, 2008 and December 31, 2013, a total
of 114 patients (M/F: 74/40) underwent 144 MRI-scans
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for routine LIC measurement. Patient characteristics and
clinical indications for LIC measurement are described in
Table 2. Thirty patients had multiple measurements. To
prevent a repeated measurements effect on correlation
assessment between LICSIR, R2, and R2*, only the 114
baseline measurements were used. SIR, R2, and R2* data
were available for 108/114 (95%), 72/114 (63%), and 113/
114 (99%) baseline measurements.
MRI success rates
Five SIR measurements were classiﬁed unsuccessful be-
cause a surface coil was used, one due to erroneous TR/
TE combinations. Furthermore, image quality was
inadequate (respiration artifacts) in a single patient (only
R2 and R2* acquired). Hence, SIR was successful in 102/
114 (89%), R2 in 71/114 (62%), and R2* in 112/114 (98%)
subjects. The success rate of R2 was lower than that of
SIR and R2* (P < 0.0001, each). Missing datasets were
presumed to not have been scanned, with time con-
straints and respiratory triggering problems as the major
cause of the low success rate of the R2 measurement. For
subsequent analyses, only successful baseline measure-
ments were used.
Interobserver agreement
LICSIR and R2 values differed between observer 1 and
the other observers (Table 3). However, these differences
(median values: 80–85 lmol/g and 33–34 Hz for R2)
would be negligible in clinical practice. This was con-
firmed by high ICCs for SIR, R2, and R2* of 0.998,
0.997, and 0.999, respectively. Bland–Altman analysis
between pairs of observers showed a single outlier for
SIR, while R2 and R2* showed differences up to 5% for
higher values, reflecting the uncertainties in the data fit at
very high LIC (Online Resource 1).
LICSIR, R2, and R2*
Median (IQR) LICSIR, R2, and R2* (given for observer 1
and LICSIR <350 lmol/g) were 84 (30–205), 33 (23–48),
and 123 (56–321). LICSIR correlated positively with R2
and R2* with rS of 0.90 (95% confidence interval (CI)
0.84–0.94, P < 0.0001, n = 57) and 0.98 (95% CI 0.97–
0.99, P < 0.0001, n = 87), respectively. R2 correlated
positively with R2*: rS of 0.95 (95% CI 0.93–0.97,
P < 0.0001, n = 71). Figure 2A, B shows scatter plots
of (SIR-based or biopsy-proven) LIC against R2 and
R2*. Solid lines indicate regression analysis results (95%
CI bands as dashed lines). In our patient cohort, R2 in-
creased linearly with LICSIR (Eq. 5), while R2* appeared
to have a clear non-linear relationship with LICSIR, well
described by a quadratic polynomial (Eq. 6).
R2 ¼ 15:5þ 0:107  LICSIR ð5Þ
R2
 ¼ 42:7þ 0:142  LICSIR þ 4:02 103  LICSIR2 ð6Þ
The LICSIR upper threshold of 350 lmol/g was
reached in 15/102 (15%) measurements. In these mea-
surements, only the T1W SIR correlated with R2*, with
rS of -0.72 (95% CI -0.9 to -0.31, P = 0.003, n = 15).
Figure 3 shows the T1 W SIR against R2*, indicating
that for LICSIR >350 lmol/g, the discriminatory value
of the T1W SIR becomes progressively smaller.
Comparison with the literature
Figure 2A, B also shows published regression lines be-
tween either LICSIR or LICBIOPSY and R2 (Fig. 2A) and
R2* (Fig. 2B). Contrary to our finding, these lines indi-
cate a linear increase of R2* as LIC increases, and a non-
linear increase of R2 as LIC increases. To assess whether
this is caused by LICSIR or by R2 or R2*, we applied
established conversion formulae to convert our R2
(Eq. 7) and R2* (Eq. 8) values to LIC values [8, 20]. We









5:585  102 ð8Þ
These established conversion formulae show a non-
linear relation between R2 and true LIC (Eq. 7) and
Table 2. Patient characteristics
Number (%) or median (IQR)
Patients 114
Male/female 74/40 (65/35%)
Age (years) 44 (28.5–58.1)
Indications
Sickle cell anemia 21/114 (19%)
MDSa/leukemia 19/114 (17%)
Thalassemia 17/114 (15%)
Gaucher’s disease 16/114 (14%)
Hemochromatosis 14/114 (12%)
Hemosiderosis (not specified) 6/114 (5%)
Other 21/114 (18%)
a MDS myelodysplastic syndrome
Table 3. MRI interobserver agreement: median (IQR) values
MRI method Observer 1 Observer 2 Observer 3 P value
LICSIR (lmol/g) 84 (30–205) 80 (25–197) 85 (26–196) <0.001
a
R2 (Hz) 33 (23–48) 34 (24–49) 34 (24–49) <0.001
a
R2* (Hz) 123 (56–321) 126 (55–326) 123 (55–317) 0.092
a Post hoc analysis using Wilcoxon Signed-Rank tests showed that
LICSIR and R2 values of observer 1 differed significantly from either
observer 2 or 3 (who did not differ from each other)
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linear relation between R2* and true LIC (Eq. 8). Hence,
the scatter plot between LICR2* and LICSIR also revealed
a quadratic relation, and that between LICSIR and LICR2
a linear one (data not shown).
Diagnostic accuracies of LICSIR, R2, and serum
values
Serum total iron, transferrin, transferrin-saturation, and
ferritin were available for 56, 56, 54, and 96 out of 114
measurements. All four correlated signiﬁcantly with R2*,
with best correlation for ferritin at rS = 0.80
(P < 0.0001, n = 94).
Increased R2* (‡44 Hz) was present in 91 subjects. Of
the MRI and serum methods, R2 and ferritin had best
diagnostic accuracies to detect increased R2* (Table 4).
Figure 4A–C shows true and false positive and negative
results of R2 (Fig. 4A), LICSIR (Fig. 4B), and ferritin
(Fig. 4C) for establishing increased R2*.
Discussion
This study shows that for routine clinical MRI-based
LIC measurements SIR and R2* are more often suc-
cessful than R2. Interobserver agreement was near per-
fect (ICC > 0.9) for all methods. R2 and R2* methods
provided relaxation rates when the SIR-threshold
(>350 lmol/g) was already exceeded. This gives them an
advantage over SIR in subjects with transfusional
hemosiderosis (at least 55% of our population), when
LIC values can easily surpass 350 lmol/g. The combi-
nation of high success rate, high interobserver agree-
ment, ability to detect changes in LIC over a wide range
of LIC values, and single breath-hold acquisition favors
the R2* method for LIC measurement.
In our study, the relationship between R2* and LICSIR
was quadratic and remained quadratic when R2* was ex-
pressed as a LIC value using a previously published
(biopsy-proven) conversion formula. Other authors report
linear relationships. Given the physics of the R2*–iron
relationship, which is basically linear [25], this discrepancy
arises either from our R2* acquisition and analysis or from
the reference standard. To rule out the former, we com-
pared three fit routines. The exponential + Rician noise
factor fit provided identical results in a fraction of the re-
quired time to the established and widely applied but labor-
intensive method of manual truncation before exponential
fitting.
With respect to reference standard, St. Pierre et al. [8],
Wood et al. [9], Hankins et al. [19], Garbowski et al. [20],
and Anderson et al. [21] all used biopsy-determined
LICBIOPSY as reference standard, whereas we and
Christoforidis et al. [14] used the LICSIR according to
Gandon. Given the similarity of our MRI protocols, it is
unsurprising that Christoforidis’ and our data points
show considerable overlap. Arguably, their linear rela-
A
B
Fig. 2. LICSIR or LICBIOPSY against R2 and R2*. A, B Scatter
plots of LICSIR against R2 (A, top) and R2* (B, bottom) for all
successful baseline measurements. Data points are grouped
by SIR LIC type: T1; PD; T2; T2+; and T2++.
Regression results (equations given in the figures) are shown
by solid lines, with dotted 95% CI bands indicating the
goodness of the fit. Additional dotted regression lines are
based on regression analyses reflecting LICBIOPSY [8, 9, 19–
21] or LICSIR [14].
Fig. 3. T1W liver-to-muscle SIR against R2*. This shows a
scatter plot of R2* values (x-axis) against the liver-to-muscle
SIR (y-axis) of successful baseline T1W SIR measurements.
Data are grouped into the following: LICSIR <350 and
LICSIR >350 lmol/g.
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tion between LICSIR and R2* could also be described by
a quadratic polynomial.
Apart from the linear relationship, the other authors
report much steeper increase of R2* as LIC increases [9,
19–21]. Anderson et al.’s very steep increase could be due
a long TE1 of 2.2 ms compared to all other studies
(range of TE1: 0.8–0.99 ms) that hampers the ability to
accurately estimate high R2* values. The fact that the
control values of R2* in subjects without iron overload in
those studies but also in this paper hover around 40 Hz is
a further argument that the observed difference in LIC–
R2* does not arise from the R2* acquisition or analysis
but from the reference standard.
Hence, the most likely cause of the deviating quad-
ratic relation between R2* and estimated LIC is the
piecewise sampling of the LIC range with five differently
weighted GRE-sequences for LICSIR. This has artificially
imposed a quadratic behavior on the actually linear
relationship between R2* and true LICBIOPSY. If one
looks at the fundamental GRE signal equation (Eq. 9),
where PD is proton density and a is flip angle and applies
this to the liver-to-muscle signal intensity ratio, the PD
and sin(a) terms drop out. By taking the natural loga-
rithm, we find Eqs. 10 and 11. The latter proves that the
relationship between R2* and SIR is logarithmic. Indeed,
plotting Fig. 3 with a log-scale for the signal intensity
ratio on the y-axis linearized the line (data not shown).
S TEð Þ ¼ PD  sin að Þ  1 e
TR=T1 














 f TR; a;T1ð Þ
TE
þ R2;MUSCLE ð11Þ
For R2, single- and multiecho SE acquisitions are
possible: multiecho SE decreases R2 due to residual sig-
nal of stimulated echoes at a given TE. Single-echo SE
increases R2 because long TEs cause increased sensitivity
to diffusion, hence increased signal loss at a given TE.
Reported single-echo SE R2 values [8, 9] were concor-
dantly higher for the same estimated LIC compared to
multiecho SE results as in this study and in [14]. In terms
of R2 data fitting, we as many others applied a biexpo-
nential model and we did not assess non-exponential
decay models as for instance proposed by Jensen et al.
[26].
The main limitation of our study is the lack of biopsy
conﬁrmation. In our center, liver biopsy for iron deter-
mination is seldom performed. Both the national,
European and American guidelines recommend reluc-
tance in performing biopsy and underline the high sen-
sitivity of MRI [15, 27, 28]. Moreover, differing
processing steps to obtain LICBIOPSY are reported,
compromising generalizability. In Gandon’s method,
paraffin-embedded liver biopsy specimens are dewaxed
using a protocol with a triple xylene wash to remove lipid
solids from the sample. This approach was shown to
have an elevating effect on the dry weight liver iron
calculation compared to processing fresh tissue samples
[29]. Another limitation is the fact that we did not per-
form multipeak fat-correction on complex data [10]. This
was not feasible with only magnitude data available.
Comparison to other literature is further hampered by
the use of different image acquisition and postprocessing
protocols which directly influence the calibration curves
between the reference standard and the index test. We
have opted to compare our findings to calibration curves
obtained with similar postprocessing protocols.
ROC-analyses showed that R2 and ferritin have the
highest diagnostic accuracy to identify increased R2*
(‡44 Hz). Both ferritin (‡524 lg/L) and R2 (‡18.3 Hz)
had positive predictive values of 100%, but the wide
distribution of ferritin levels for R2* ‡ 44 Hz indicates
that it cannot be used confidently to follow-up treatment
nor accurately determine the LIC. In contrast, R2 shows
a different picture with a close distribution around the
regression line. In addition, ferritin lacks the spatial
information that MRI provides, allowing segmental LIC
measurement and follow-up.
R2 datasets were missing (i.e., not scanned) in 42/114
(37%) subjects. As R2 is part of our routine scan proto-
col, this illustrates that the long and artifact-prone R2
Table 4. Diagnostic accuracy values to correctly identify increased R2* (‡44 Hz)
R2 LICSIR Iron Transferrin Transferrin-% Ferritin
Cases 64/64 75/80 18/41 36/41 20/40 72/80
Cut-off ‡18.3 Hz ‡36 mg/g ‡22.6 £2.21 ‡0.40 ‡524
AUROC 1.00 (0.95–1.0) 0.97 (0.91–0.99) 0.66 (0.53–0.79) 0.84 (0.72–0.93) 0.77 (0.64–0.87) 0.98 (0.93–1.0)
Sensitivity 100% (94.4–100%) 93.8% (86.0–97.9%) 43.9% (28.5–60.3%) 87.8% (73.8–95.9%) 50.0% (33.8–66.2%) 90.0% (81.2–95.6%)
Specificity 100% (59.0–100%) 100% (83.9–100%) 100% (76.8–100%) 71.4% (41.9–91.6%) 92.3% (64.0–99.8%) 100% (76.8–100%)
PPV 100% (93.7–100%) 100% (95.2–100%) 100% (82.6–100%) 92.4% (79.8–98.3%) 96.3% (78.3–100%) 100% (94.7–100%)
NPV 100% (77.3–100%) 80.2% (59.7–93.2%) 31.1% (16.7–48.7%) 59.7% (30.3–84.7%) 31.8% (16.4–50.9%) 71.7% (51.0–87.3%)
AUROC area under the ROC curve, PPV positive predictive value, NPV negative predictive value
Values in parentheses reflect the 95% confidence intervals
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series is skipped first by the radiographer. This makes the
R2 series less suited as first choice for LIC measurement.
Our results favor the use of R2* measurements for
daily clinical practice with the use of an exponen-
tial + Rician noise fit method to save time in analysis.
The recommendation to (only) use R2* comes with
cautions. It requires careful consideration of scan
parameters which should be kept equal for all measure-
ments. Ideally, routine quality control with phantom
testing should be performed.
In conclusion, as R2* can be obtained in a single
breath-hold with excellent success rates, high interob-
server agreement, and ability to detect changes over a
wide range of LIC values and is available from all major
vendors without additional per-scan costs, it is our first
choice for LIC measurement.
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